Hideyuki Akaza, M.D.
Department of Strategic investigation on comprehensive cancer network Interfaculty Initiative in Information Studies/Graduate School of Interdisciplinary Information Studies.
The University of Tokyo, Japan
- 1980
- M.D. The University of Tokyo, Japan
- 1982
- Visiting assistant professor, University of Tennessee, USA
- 1986
- Lecturer, Department of Urology, Faculty of Medicine, the University of Tokyo
- 1990-1996
- Associate professor, Department of Urology, Institute of Clinical Medicine, University of Tsukuba
- 1997-2004
- Professor and Chairman, Department of Urology, Institute of Clinical Medicine, University of Tsukuba 2000-2009 Deputy Director of Tsukuba University Hospital
- 2004-2010
- Professor & Chairman, Urology & Andrology, Doctoral Program in Clinical Sciences, Post-graduate, University of Tsukuba
- 2008-2010
- Director, Tsukuba General Cancer Clinic Center
- 2010-
- Emeritus Professor, University of Tsukuba
- 2010-2015
- Professor, Research Center for Advanced Science and Technology, the University of Tokyo
- 2014-
- Member, Interfaculty Initiative in Information Studies/Graduate School of Interdisciplinary Information Studies, The University of Tokyo
- 2015-
- Professor, Interfaculty Initiative in Information Studies/Graduate School of Interdisciplinary Information Studies, The University of Tokyo
- The Japanese Urological Association Sakaguchi Prize (1982)
- Executive member of Japan Society of Clinical Oncology (1999-2006)
- Expert committee member of Ministry of Health, Labour and Welfare
- Executive member of The Japanese Urological Association
- Executive member of Japanese Biotherapy Association
- Committee member of Japanese Cancer Association
- President of The 44th Annual Meeting of Japan Society of Clinical Oncology (2006)
- The Japan Society of Clinical Oncology Komei Nakayama Prize (2007)
- Chairperson of 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment
- President of the 20th Asia Pacific Cancer Conference
- President of Asia Pacific Society of Urological Oncology
- Director of UICC-ARO (Asian regional office)
- Member of UICC TNM Expert Panel Genitourinary Cancer
- Vice Secretary General of the Asian and Pacific Federation of Organization for Cancer Research and Control (APFOCC)
- Chair of NCCN Asian Consensus Statement
- Distinguished Service Award for Japanese Urology (2014)
- Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy. J Clin Oncol 2009;27: 4306-4313
- Combined immunotherapy with low-dose IL-2 plus IFN-alpha for metastatic renal cell carcinoma: survival benefit for selected patients with lung metastasis and serum sodium level. Jpn J Clin Oncol. 2011; 41: 1023-30.
- Prostate Cancer Chemoprevention by Soy isoflavones-Role of intestinal bacteria as the "second human genome". Cancer Sci 2012; 103: 969-75.
- Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine. Cancer Sci 2013; 104(1):22-7.
- Union for International Cancer Control International Session: Healthcare Economics: The significance of the UN summit non-communicable diseases political declaration in Asia. Cancer Sci 2013; 104(6):773-8
- Cross-boundary Cancer Studies at the University of Tokyo: Surviving Cancer in Asia, Ed. Akaza H, Kawahara N, Jpn J Clin Oncol,2014; 44(Supple 1)